The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcomes of HIV-positive lymphoma patients treated in the highly active antiretroviral therapy (HAART) era.
M. A. Fanale
Disclosure not yet available
K. Vigil
Disclosure not yet available
C. Lai
Disclosure not yet available
L. Feng
Disclosure not yet available
W. Dong
Disclosure not yet available
A. Younes
Disclosure not yet available
J. E. Romaguera
Disclosure not yet available
L. Fayad
Disclosure not yet available
F. B. Hagemeister
Disclosure not yet available
V. Mulanovich
Disclosure not yet available